234 related articles for article (PubMed ID: 29167929)
21. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
[TBL] [Abstract][Full Text] [Related]
22. Polymer coating on a micropillar chip for robust attachment of PuraMatrix peptide hydrogel for 3D hepatic cell culture.
Roth AD; Lama P; Dunn S; Hong S; Lee MY
Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():634-644. PubMed ID: 29853133
[TBL] [Abstract][Full Text] [Related]
23. Evolution of Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates.
Andersson TB
Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):234-238. PubMed ID: 28470941
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Hepatic Functions of Genetically Modified Mouse Hepatoma Cells by Spheroid Culture for Drug Toxicity Screening.
Sarkar J; Kumari J; Tonello JM; Kamihira M; Kumar A
Biotechnol J; 2017 Oct; 12(10):. PubMed ID: 28834334
[TBL] [Abstract][Full Text] [Related]
25. A photoclickable peptide microarray platform for facile and rapid screening of 3-D tissue microenvironments.
Sharma S; Floren M; Ding Y; Stenmark KR; Tan W; Bryant SJ
Biomaterials; 2017 Oct; 143():17-28. PubMed ID: 28756193
[TBL] [Abstract][Full Text] [Related]
26. Drug Evaluation Based on a Multi-Channel Cell Chip with a Horizontal Co-Culture.
Kim GJ; Lee KJ; Choi JW; An JH
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209790
[TBL] [Abstract][Full Text] [Related]
27. HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved.
Tolosa L; Gómez-Lechón MJ; Pérez-Cataldo G; Castell JV; Donato MT
Arch Toxicol; 2013 Jun; 87(6):1115-27. PubMed ID: 23397584
[TBL] [Abstract][Full Text] [Related]
28. Competency of different cell models to predict human hepatotoxic drugs.
Gómez-Lechón MJ; Tolosa L; Conde I; Donato MT
Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1553-68. PubMed ID: 25297626
[TBL] [Abstract][Full Text] [Related]
29. Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury.
Proctor WR; Foster AJ; Vogt J; Summers C; Middleton B; Pilling MA; Shienson D; Kijanska M; Ströbel S; Kelm JM; Morgan P; Messner S; Williams D
Arch Toxicol; 2017 Aug; 91(8):2849-2863. PubMed ID: 28612260
[TBL] [Abstract][Full Text] [Related]
30. Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing.
Gómez-Lechón MJ; Tolosa L; Donato MT
Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):137-148. PubMed ID: 27671376
[TBL] [Abstract][Full Text] [Related]
31. Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering.
Donato MT; Jover R; Gómez-Lechón MJ
Curr Drug Metab; 2013 Nov; 14(9):946-68. PubMed ID: 24160292
[TBL] [Abstract][Full Text] [Related]
32. A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies.
Ramaiahgari SC; den Braver MW; Herpers B; Terpstra V; Commandeur JN; van de Water B; Price LS
Arch Toxicol; 2014 May; 88(5):1083-95. PubMed ID: 24599296
[TBL] [Abstract][Full Text] [Related]
33. A high content screening assay to predict human drug-induced liver injury during drug discovery.
Persson M; Løye AF; Mow T; Hornberg JJ
J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
[TBL] [Abstract][Full Text] [Related]
34. A 96-well microplate bioreactor platform supporting individual dual perfusion and high-throughput assessment of simple or biofabricated 3D tissue models.
Parrish J; Lim KS; Baer K; Hooper GJ; Woodfield TBF
Lab Chip; 2018 Sep; 18(18):2757-2775. PubMed ID: 30117514
[TBL] [Abstract][Full Text] [Related]
35. Micro-scaffold array chip for upgrading cell-based high-throughput drug testing to 3D using benchtop equipment.
Li X; Zhang X; Zhao S; Wang J; Liu G; Du Y
Lab Chip; 2014 Feb; 14(3):471-81. PubMed ID: 24287736
[TBL] [Abstract][Full Text] [Related]
36. Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity.
Tao G; Huang J; Moorthy B; Wang C; Hu M; Gao S; Ghose R
Expert Opin Drug Metab Toxicol; 2020 Nov; 16(11):1109-1124. PubMed ID: 32841068
[TBL] [Abstract][Full Text] [Related]
37. 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies.
Mueller D; Krämer L; Hoffmann E; Klein S; Noor F
Toxicol In Vitro; 2014 Feb; 28(1):104-12. PubMed ID: 23850736
[TBL] [Abstract][Full Text] [Related]
38. High-throughput toxicity testing of chemicals and mixtures in organotypic multi-cellular cultures of primary human hepatic cells.
Orbach SM; Ehrich MF; Rajagopalan P
Toxicol In Vitro; 2018 Sep; 51():83-94. PubMed ID: 29751030
[TBL] [Abstract][Full Text] [Related]
39. Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury.
Tolosa L; Jiménez N; Pérez G; Castell JV; Gómez-Lechón MJ; Donato MT
Arch Toxicol; 2018 Jan; 92(1):383-399. PubMed ID: 28762043
[TBL] [Abstract][Full Text] [Related]
40. Hepatotoxicity assay using human hepatocytes trapped in microholes of a microfluidic device.
Yeon JH; Na D; Park JK
Electrophoresis; 2010 Sep; 31(18):3167-74. PubMed ID: 20872616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
